Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

References

• Centers for Disease Control and Prevention, National Center for Health Statistics [webpage on the Internet]Underlying Cause of Death 1999–2013 on CDC WONDER Online Database, Released 2015. Data Are from the Multiple Cause of Death Files, 1999–2013, as Compiled from Data Provided by the 57 Vital Statistics Jurisdictions through the Vital Statistics Cooperative Program2015 Available from: http://wonder.cdc.gov/ucd-icd10.htmlAccessed February 3, 2015
   Google Scholar
• U. S. Census BureauThe next four decades The older population in the United States: 2010 to 2050Washington, DCU.S. Department of Commerce2010 Available from: https://www.census.gov/prod/2010pubs/p25-1138.pdfAccessed June 14, 2015
   Google Scholar
• HeidenreichPATrogdonJGKhavjouOAAmerican Heart Association Advocacy Coordinating CommitteeStroke CouncilCouncil on Cardiovascular Radiology and InterventionCouncil on Clinical CardiologyCouncil on Epidemiology and PreventionCouncil on ArteriosclerosisThrombosis and Vascular BiologyCouncil on CardiopulmonaryCritical CarePerioperative and ResuscitationCouncil on Cardiovascular NursingCouncil on the Kidney in Cardiovascular DiseaseCouncil on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes ResearchForecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart AssociationCirculation2011123893394421262990
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNAmerican College of Cardiology F American Heart AImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation200411022723915249516
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAHAmerican College of Cardiology/American Heart Association Task Force on Practice G2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 suppl 2S1S4524222016
   PubMed Web of Science ®Google Scholar
• BaigentCKeechAKearneyPMCholesterol Treatment Trialists CEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ (CTT) CollaborationBaigentCBlackwellLEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet201037697531670168121067804
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists CMihaylovaBEmbersonJThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsLancet2012380984158159022607822
   PubMed Web of Science ®Google Scholar
• LingGAntiplatelet therapy for secondary prevention in stroke making the right choiceCurr Vasc Pharmacol201210222523722022772
   PubMed Web of Science ®Google Scholar
• ThavendiranathanPBagaiABrookhartMAChoudhryNKPrimary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trialsArch Intern Med2006166212307231317130382
   PubMedGoogle Scholar
• CannonCPThe next step in cardiovascular protectionAtheroscler Suppl20034539
   PubMed Web of Science ®Google Scholar
• LaRosaJCAt the heart of the statin benefitJ Am Coll Cardiol20054610186316286172
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program Expert Panel on Detection E and Treatment of High Blood Cholesterol in AThird Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• PencinaMJNavar-BogganAMD’AgostinoRBSrApplication of new cholesterol guidelines to a population-based sampleN Engl J Med2014370151422143124645848
   PubMed Web of Science ®Google Scholar
• KoenigsfeldCSaylerMSmithHLRetrospective evaluation of ASCVD risk and statin therapy need in nondiabetic patients based on the 2013 ACC/AHA cholesterol guidelinesJ Pharm Pract201730330030527026635
   PubMedGoogle Scholar
• TranJNCaglarTStocklKMLewHCSolowBKChanPSImpact of the new ACC/AHA guidelines on the treatment of high blood cholesterol in a managed care settingAm Health Drug Benefits20147843044325558305
   PubMedGoogle Scholar
• WasserTWeBYcasJTunceliOApplying weighting methodologies to a commercial database to project US Census Demographic DataAm J Acc Care20159153338
   Google Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care2005431130113916224307
   PubMed Web of Science ®Google Scholar
• U.S. Bureau of Labor Statistics [database on the Internet]Consumer Price Index (CPI) for Medical Care2014 Available from: http://data.bls.govAccessed March 6, 2014
   Google Scholar
• MoranJLSolomonPJPeisachARMartinJNew models for old questions: generalized linear models for cost predictionJ Eval Clin Pract200713338138917518803
   PubMed Web of Science ®Google Scholar
• ViraniSSWoodardLDAkeroydJMRamseyDJBallantyneCMPetersenLAIs high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management GuidelinesClin Cardiol2014371165365925324147
   PubMed Web of Science ®Google Scholar
• RosensonRSKentSTBrownTMUnderutilization of high-intensity statin therapy after hospitalization for coronary heart diseaseJ Am Coll Cardiol201565327027725614424
   PubMed Web of Science ®Google Scholar
• JacobsonTAItoMKMakiKCNational Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 – executive summaryJ Clin Lipidol20148547348825234560
   PubMed Web of Science ®Google Scholar
• RaymondCChoLRoccoMHazenSLNew cholesterol guidelines: worth the wait?Cleve Clin J Med2014811111924391101
   PubMed Web of Science ®Google Scholar
• ColantonioLDHuangLMondaKLAdherence to high-intensity statins following a myocardial infarction hospitalization among Medicare beneficiariesJAMA Cardiol20172889089528423147
   PubMed Web of Science ®Google Scholar
• StainNRidgeDCheshireAGender comparisons in non-acute cardiac symptom recognition and subsequent help-seeking decisions: a mixed methods study protocolBMJ Open2014410e005742
   PubMed Web of Science ®Google Scholar
• GulatiMMerzCNNew cholesterol guidelines and primary prevention in womenTrends Cardiovasc Med2015252849425442733
   PubMed Web of Science ®Google Scholar
• FihnSDGardinJMAbramsJ2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsJ Am Coll Cardiol20126024e44e16423182125
   PubMed Web of Science ®Google Scholar